StatLab Medical Products, a McKinney-based global developer and manufacturer of medical diagnostic equipment and supplies, has begun injection molding manufacturing at a new histology consumable manufacturing facility in Arlington.
The company said the facility represents a new era of innovation and transformational opportunity for StatLab, with a new essential manufacturing capability for histology solutions now actively operating in the United States.
StatLab said its 2022 acquisition of Wales-based CellPath Ltd., known for injection molding manufacturing of histology supplies, served as a catalyst for this expansion. Other planned capability expansions at the Arlington site include blow molding as well as glass slide manufacturing, the company said.
“As we expand sales of PiSmart Cassette printers here in the U.S. market, giving customers confidence in a readily available supply of the consumable cassettes used with the printer is imperative,” StatLab CEO Dae Hong said in a statement. “None of this would have been possible without the help of our Newtown, Wales operational and technical teams to support this key capability expansion. We are grateful for their collaboration and partnership to build on their experience spanning more than 30 years with high-quality precision injection molding.”
StatLab now has six facilities across the U.S., United Kingdom, and Germany
The addition of the Arlington plant expands the StatLab in-house manufacturing network to a total of six locations across the United States, United Kingdom, and Germany, making the supply chain shorter, more reliable, and more effective, according to the company, which was founded in 1976.
Injection molding at the 35,000-square-foot facility in Arlington will give laboratories the confidence of additional core histology consumables produced by StatLab in the U.S., the company said. The facility has room for further expansion, StatLab said.
The company said that onsite injection molding capabilities support not only histology cassette manufacturing but also additional components and packaging materials to further reduce the carbon footprint of products, reduce costs, and empower more value for customers while offering more control over the product development ecosystem and supply chain.
StatLab said its new manufacturing capabilities provide flexibility to meet market needs while expanding the company’s portfolio of manufactured cassettes to include a wide variety of styles compatible not only with the PiSmart printer, but also with other on-market printers as well as for manual use.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.